WisdomTree BioRevolution Fund Rating $17.28 -0.43 (-2.43%) As of 05/15/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.72Holdings in WDNA have an aggregate rating of Moderate Buy based on 432 analyst ratings issued in the past year covering 24 companies (54.8% of the portfolio).WDNA Aggregate Price Target$17.28High Prediction$17.28Average Prediction$17.28Low Prediction$17.28Holdings in WDNA have an aggregate price target of $17.28 and a range of $17.28 to $17.28 covering 24 companies (54.8% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 WDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.79%LLYEli Lilly and Company$1,005.20-0.1%4.9027 of 5 stars2.87$1,218.33 21.2%30Trending NewsAnalyst Revision3.75%TWSTTwist Bioscience$49.17-7.1%2.5125 of 5 stars2.75$56.57 15.1%8Insider Trade3.61%MRNAModerna$49.04-2.0%1.6011 of 5 stars1.84$35.73 -27.1%19Gap Down2.99%JNJJohnson & Johnson$226.81-1.7%4.6469 of 5 stars2.74$253.04 11.6%27Trending NewsAnalyst Upgrade2.97%UTHRUnited Therapeutics$568.58-1.3%3.6527 of 5 stars2.85$619.42 8.9%13Trending NewsInsider TradeAnalyst Revision2.83%IMNMImmunome$20.88-5.2%3.4856 of 5 stars2.92$32.82 57.2%12Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down2.61%DARDarling Ingredients$62.35-0.7%3.775 of 5 stars3.08$69.00 10.7%13Positive NewsAnalyst ForecastAnalyst Revision2.41%STOKStoke Therapeutics$30.08-4.1%2.3941 of 5 stars2.73$41.83 39.1%11Analyst Revision2.25%CTVACorteva$82.17-1.4%4.028 of 5 stars2.59$88.14 7.3%22Analyst Forecast2.23%BEAMBeam Therapeutics$27.93-5.4%3.5153 of 5 stars2.71$46.83 67.7%14Trending NewsAnalyst ForecastAnalyst RevisionGap Down2.20%TEMTempus AI$43.93-3.4%3.325 of 5 stars2.50$68.64 56.3%142.06%BGBunge Global$122.38-0.6%4.4858 of 5 stars2.91$132.67 8.4%112.04%IONSIonis Pharmaceuticals$74.23-1.9%3.3726 of 5 stars2.86$99.35 33.8%212.02%CRSPCRISPR Therapeutics$48.41-4.0%3.2308 of 5 stars2.53$65.47 35.2%19Analyst Forecast1.97%NTRANatera$186.36-5.4%3.8565 of 5 stars2.79$256.60 37.7%19Analyst Forecast1.90%KRYSKrystal Biotech$306.29-3.2%2.7202 of 5 stars2.83$324.11 5.8%12Positive News1.84%GILDGilead Sciences$129.58-1.9%4.7706 of 5 stars2.86$157.04 21.2%28Analyst Revision1.74%GPCRStructure Therapeutics$38.69-2.9%3.1562 of 5 stars2.89$109.25 182.4%19Positive NewsAnalyst DowngradeAnalyst RevisionGap Down1.66%PFEPfizer$25.31-1.7%4.0597 of 5 stars2.23$28.84 14.0%22Trending NewsAnalyst ForecastAnalyst Revision1.64%ROIVRoivant Sciences$29.29-0.7%2.022 of 5 stars2.75$30.55 4.3%12Positive News1.62%AMGNAmgen$326.31-3.0%4.05 of 5 stars2.48$356.15 9.1%31Analyst Forecast1.62%ARWRArrowhead Pharmaceuticals$76.67-3.8%2.1944 of 5 stars2.83$87.80 14.5%12Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.58%TMOThermo Fisher Scientific$438.16-2.2%4.7752 of 5 stars2.96$616.10 40.6%23Positive NewsAnalyst Upgrade1.50%RVMDRevolution Medicines$145.66-2.5%2.2906 of 5 stars3.10$103.88 -28.7%20 This page (BATS:WDNA) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX Goes Public. Here's What Happens To Your IRA.When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts